Welcome : Guest

Sino Biopharmaceutical Ltd. (Hong Kong) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Sino Biopharmaceutical Ltd., which is principally involved in Pharmaceuticals Business. Illustrated with 119 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-09310
Price: $3500
Company Type: Public
Pages: 124
Date: January 2017
Market Data Tables: 119

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Hepatitis Drug......6
Table 1: Hepatitis Drug Market in China (2015) in Rmb Million......6
Diabetes......7
Table 2: Diabetes Market by Region Worldwide (2015) - Percentage Share Breakdown for Africa, Europe, Middle East & North Africa, North America & Caribbean, Southeast Asia, and Western Pacific......7
Table 3: Diabetes Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Insulin Type-1 Diabetes, Insulin Type-2 Diabetes, Dipeptidyl Peptidase 4, (DPP4), Glucagon-like Peptide-1 (GLP-1), Dipeptidyl Peptidase 4, (DPP4) + Biguanide, and Others* (includes Sodium-Glucose Co-Transporter-2 (SGLT2), Biguanide, Sulfonylurea, Alpha-Glucosidase Inhibitors, Peroxisome Proliferator-Activated Receptor (PPAR)......8
Table 4: Diabetes Care Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for Human Insulins, Modern Insulins, Victoza, and Others......9
Table 5: Type-II Diabetes Treatments Market Worldwide (2015-2020) in US$ Million......10
Table 6: Type II Diabetes Market by Treatment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-IV Inhibitors, GLP-1 Agonists, SGLT-2 Inhibitors and Thiazolidinediones......11
Table 7: Type II Diabetes Market by Insulin Treatment Worldwide (2015) - Percentage Share Breakdown by Value for Diet and Exercise Only, Insulin and Orals and Insulin Only......12
Table 8: Diabetes Healthcare Market by Category in the US (2015) - Percentage Share Breakdown by Value for Anti -Diabetic Agents & Supplies, Doctor Office Visits, Hospital Care, Nursing/Residential Facility Stays, Prescription Medication, and Others......13
Table 9: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown for Insulin Pumps, and Multiple Daily Injections......14
Table 10: Diabetes Market by Type in the US (2015) - Percentage Share Breakdown by Value for Type 1, and Type 2......15
Table 11: No. of Diabetes Patients by Medication in the US (2015) - Percentage Share Breakdown for Insulin and Oral Medication, Insulin Only, No Medication, and Oral Medication Only......16
Diabetes Drugs......17
Table 12: Diabetes Drug Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value for DPP-4 Inhibitor, GK Activator, GLP-1 Agonist, GPCR Agonist, IL- Receptor Antagonist, Insulin Analogue, PPAR Agonist, SGLT-2 Inhibitor, and Others......17
Table 13: Diabetes/Metabolic Drugs Market by Category Worldwide (2015) - Percentage Breakdown by Value Sales for DPP-IV Inhibitors, Glitazones, GLP-1 Analogs, Insulins, Sulfonylureas, and Others......18
Table 14: Anti-Diabetic Drug Market by Treatment Class Worldwide (2015) - Percentage Share Breakdown by Value for Diet & Exercise, Incretion, Insulin and Oral Anti-Diabetic......19
Table 15: Antidiabetes Molecules Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for Metformin, Sulfonylureas, Thiazolidin Ediones and Others......20
Table 16: Anti-Diabetic Drugs Market in China (2015-2020) in RMB Million......21
Table 17: Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glinide, Insulin, Sulfonylureas, α-glucosidase Inhibitor, and Others......22
Table 18: Anti-Diabetic Drugs Market by Category in China (2015) - Percentage Share Breakdown by Value for Insulin Drugs and Non-Insulin Drugs......23
Table 19: Diabetes Drugs Market by Product Category in China (2015) - Percentage Share Breakdown by Value for Acarbose, Insulin, Melbine, and Other Diabetes Drugs......24
Table 20: Diabetic Drugs Market by Category in the US (2015) - Percentage Share Breakdown by Value for DPP-IV & SGLT-2, GLP-1, Insulins, and Others......25
Table 21: Diabetic Drugs Market by Non-Insulin Therapy in the US (2015) - Percentage Share Breakdown by Volume for Biguanides, DPP-4 Inhibitor, Human GLP-1 Analogs, SGLT-2 Inhibitor, Sulfonylureas, and Others......26
Table 22: Oral Diabetes Medicine Market in the US (2015) - Percentage Share Breakdown by Value Sales for Dipeptidyl Peptidase-4 (DPP4), Metformin, Sulfonylureas, and Others......27
Non-Insulin Anti-Diabetic Drugs......28
Table 23: Non-Insulin Anti-Diabetic Drugs Market by Product in China (2015) - Percentage Share Breakdown by Value for Biguanides, Glucosidase Inhibitors, Nateglinide, Sulfonylurea and Others......28
Hepatitis B......29
Table 24: No. of Hepatitis B Patients by Region in Europe (2015) - Percentage Market Share Breakdown by Volume for Eastern Europe, and Western Europe......29
Table 25: No. of Hepatitis B Patients by Country in Eastern Europe (2015) - Percentage Market Share Breakdown by Volume for Hungary, Poland, and Romania......30
Table 26: No. of Hepatitis B Patients by Country in West Europe (2015) - Percentage Market Share Breakdown by Volume for France, Germany, Italy, Netherlands, Spain, United Kingdom, and Others......31
Hepatitis C......32
Table 27: Hepatitis C Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Immuno Modulator, Polymerase Inhibitor, Protease Inhibitors, and Others* (Includes Ribavirin)......32
Table 28: Hepatitis C Market by Genotype Worldwide (2015) - Percentage Share Breakdown by Value for Genotype 1, Genotype 2 and Others......33
Table 29: Hepatitis C Virus Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Immuno-Modulator, Polymerase Inhibitor, Protease Inhibitors, Ribavirin, and Others......34
Table 30: Hepatitis C Virus Market by Patient Conditions in Europe (2015) - Percentage Share Breakdown by Value for Diagnosed, Prevalence, Under Care and Others......35
Table 31: No. of Hepatitis C Virus (HCV) Patients by Category in European Union (EU) (2015) - Percentage Market Share Breakdown for GT1, and Non-GT1......36
Table 32: Hepatitis C Virus Market by Patient Conditions in the US (2015) - Percentage Share Breakdown by Value for Diagnosed, Prevalence, Under Care and Others......37
Table 33: Health Insurance for Hepatitis C Virus (HCV) by Type in the US (2015) - Percentage Market Share Breakdown by Value for Commercial, Dual (Medicare and Medicaid), Medicaid, Medicare (Non- Dual), Prison, Uninsured, and Veteran Affairs......38
Table 34: No. of Hepatitis C Virus (HCV) Patients by Category in the US (2015) - Percentage Market Share Breakdown for GT1 HCV, GT2/3 HCV, and Others......39
Cancer Drugs......40
Table 35: Oncology/Hematology Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Blood Cell Factors, Chemopreventatives, Chemotherapeutics, Mabs, Targeted Therapies, and Others......40
Table 36: Oncology Drug Market by Region Worldwide (2015) - Percentage Share Breakdown by Value for European Union Five, Japan, US and Others......41
Cancer Market......42
Table 37: Cancer Care Expenditure by Site Worldwide (2015) - Percentage Share Breakdown for Breast, Colorectal, Lymphoma, Lung, Prostate and Others*......42
Table 38: Cancer Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Heme, Lung, Prostate, and Others......43
Table 39: Oncology Market by Cancer Type Worldwide (2015) - Percentage Share Breakdown by Value for Breast Cancer, Metastatic Colorectal Cancer, Non-Small Cell Lung Cancer, and Others......44
Table 40: Clinical Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......45
Table 41: Hereditary Oncology Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for US, and Others......46
Table 42: Cancer Market by Type in China (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Esophagus, Liver, Lung, Stomach and Others......47
Table 43: Oncology Market by Category in China (2015) - Percentage Share Breakdown by Value for Anti- Tumor Agents, Hormone Therapy, Immuno Suppresants and Immunostimulants......48
Table 44: Oncology Market by Segment in the US (2015) - Percentage Share Breakdown by Value for Solid Tumor and Others......49
Cancer Patients......50
Table 45: Breast Cancer Diagnoses by Hospital Type in the US (2015) - Percentage Share Breakdown by Volume for Community, Comprehensive, Teaching and Research, and Others......50
Table 46: No. of Colorectal Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......51
Table 47: No. of Invasive Breast Cancer Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......52
Table 48: No. of Primary Liver Cancer Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......53
Table 49: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category Worldwide (2015) - Percentage Market Share Breakdown for Imbruvica PCYC, Rituxan, Gazyva ROG, and Others......54
Table 50: No. of Cutaneous Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......55
Table 51: No. of Ocular Melanoma Patients by Region Worldwide (2015) - Percentage Market Share Breakdown for Asia, Australia, Europe, and US......56
Table 52: Female Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Lung, Breast, Colon, Rectum and Anus, Intestine, Liver, and Others......57
Table 53: Male Mortality by Cancer Type in China (2015) - Percentage Market Share Breakdown by Volume for Colon, Colon, Rectum and Anus, Intestine, Liver, Lung, and Others......58
Table 54: No. of Chronic Lymphocytic Leukemia (CLL) (1L) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......59
Table 55: No. of Chronic Lymphocytic Leukemia (CLL) (R/R) Patients by Category in European Union (2015) - Percentage Market Share Breakdown for Rituxan, Gazyva, and Others......60
Table 56: No. of Cancer Patients by Type in the US (2015) - Percentage Market Share Breakdown for Colorectal Cancer (CRC), Melanoma, Non-Squamous Non-Small-Cell Lung Cancer (NSCLC), Ovarian, Prostate, Renal Cell Carcinoma (RCC), and Squamous Non-Small-Cell Lung Cancer (NSCLC)......61
Table 57: Number of Cancer Patients by Type in the US (2015) - Percentage Share Breakdown by Volume for Bladder Cancer, Breast Cancer (Female), Colon and Rectum Cancer, Endometrial Cancer, Kidney and Renal Pelvis Cancer, Lung and Bronchus Cancer, Melanoma of the Skin, Non-Hodgkin Lymphoma, Prostate Cancer, and Thyroid Cancer......62
Table 58: No. of Cancer Patients Death by Type in the US (2015) - Percentage Share Breakdown for Breast, Colorectal, Lung, Melanoma, and Prostate......63
Table 59: New Patients with Cancer by Site in the US (2015) - Percentage Market Share Breakdown by volume for Colorectal, Lung and Bronchus, Melanoma, Pancreas, and Others......64
Table 60: Number of Cancer Patients by Type Worldwide (2015) - Percentage Share Breakdown by Volume for Bladder, Breast, Cervix Uteri, Colorectum, Liver, Lung, Non-Hodgkin lymphoma, Oesophagus, Prostate, and Stomach......65
Table 61: No. of Bladder Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Invasive Patients, and Non-Invasive Patients......66
Table 62: No. of Invasive Breast Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I and Stage II-III......67
Table 63: New Patients with Cancer in Stage 3/4 by Site in the US (2015) - Percentage Market Share Breakdown by Volume for Colorectal, Lung and Bronchus, Pancreas and Others......68
Table 64: No. of Solid Cancer Tumor Patients by Type Worldwide (2015) - Percentage Share Breakdown for Breast Cancer, Colorectal Cancer, Lung Cancer, Melanoma, and Prostate Cancer......69
Table 65: No. of Non Small Cell Lung Cancer Patients by Category in the US (2015) - Percentage Market Share Breakdown for Stage I, Stage II-III, Stage III-IV, and Undiagnozed......70
Cervical Cancer......71
Table 66: Cervical Cancer Market by HPV Type in England (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 33, HPV 45, and Others......71
Table 67: Cervical Cancer Market by HPV Type in Europe (2015) - Percentage Share Breakdown by Value for HPV 16, HPV 18, HPV 31, HPV 33, and Others......72
Hematological Cancer......73
Table 68: Hematological Cancer by Category Worldwide (2015) - Percentage Market Share Breakdown by Value Sales for Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM), and Non-Hodgkin’s Lymphoma (NHL)......73
Skin Cancer......74
Table 69: Skin Cancer by Type Worldwide (2015) - Percentage Market Share Breakdown by Volume for Basal Cell Carcinomas, Melanoma, and Squamous Cell Carcinomas......74
Cancer-Associated Mucositis......75
Table 70: Cancer-Associated Mucositis Market by Activity Worldwide (2015) - Percentage Share Breakdown by Value for Breast, Colorectal, Head and Neck, Non-Small Cell Lung cancer and Others......75
Chronic Myelogenous Leukemia (CML)......76
Table 71: Chronic Myelogenous Leukemia (CML) Market by Region Worldwide (2015) - Percentage Share Breakdown by Value Sales for Asia-Pacific, Canada, European Union, Japan, USA, and Others......76
Multiple Myeloma......77
Table 72: Multiple Myeloma by Age Group Worldwide (2015) - Percentage Share Breakdown by No. of New Cases for 45-54, 55-64, 65-74, 75-84, >84, and Others......77
Table 73: Multiple Myeloma Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Kyprolis AMGN, Pomalyst CELG, Revlimid CELG, Thalomid CELG, and Velcade TKD/JNJ......78
Orthopedics......79
Table 74: Orthopedics Market by Category Worldwide (2015) - Percentage Share Breakdown by Volume Sales for Biologics, CMF, Dental Implants, Extremities, Hips, Knees, Spine, Sports Medicine, and Trauma......79
Respiratory Drugs......80
Table 75: Respiratory Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue, and Rhinitis......80
Table 76: Respiratory Therapeutic Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for Prevention, Rescue and Rhinitis......81
Pharmaceuticals (Prescription)......82
Table 77: Pharmaceuticals Prescription Market by Product in the US (2015) - Percentage Share Breakdown by Value Sales for Amlodipine, Hydrocodone/Acetaminophen, Levothyroxine, Lisinopril, Metformin, Metoprolol, Omeprazole, Salbutamol, Simvastatin, and Others......82
Adefovir Dipivoxil (Mingzheng) Medicine......83
Table 78: Market Shares of Leading Adefovir Dipivoxil (Mingzheng) Medicine Manufacturers by Value Sales in China (2015) - Percentage Share Breakdown for Fujian Cosunter Pharmaceutical Co., Ltd., GlaxoSmithKline plc, Sino Biopharmaceutical Ltd. and Tianjin Jin Yao Group Co., Ltd.......83
Alprostadil Injection (Kaishi)......84
Table 79: Market Shares of Leading Alprostadil Injection (Kaishi) Manufacturers by Value Sales in China (2015) - Percentage Share Breakdown for Beijing Tide Pharmaceutical Co., Ltd., Harbin Pharmaceutical Group Co., Ltd., Sihuan Pharmaceutical Holdings Group Ltd., Xi’an Libang Pharmaceutical Co., Ltd., and Others......84
Entecavir Drug......85
Table 80: Market Shares of Leading Entecavir Drug Manufacturers by Value Sales in China (2015) - Percentage Share Breakdown for Bristol-Myers Squibb Co., Sino Biopharmaceutical Ltd., and Others......85
Hepatopathy......86
Table 81: Market Shares of Leading Medicines for the Treatment of Hepatopathy in China (2015) - Percentage Share Breakdown by Value for Ademetionine, Glycyrrhizin, Polyene Phosphatidylcholine, Tianqingganmei, and Others......86
Cardio-Cerebral Vascular (CCV) Drugs......87
Table 82: Market Shares of Leading Cardio-Cerebral Vascular (CCV) Drugs Manufacturers in China (2015) - Percentage Share Breakdown by Value for Sihuan Pharmaceutical Holdings Group Ltd., Sanofi S.A., Qilu pharmaceutical Co., Ltd. and Others......87
Metformin......88
Table 83: Market Shares of Leading Sitagliptin/Metformin Manufacturers by Value Sales in India (2015) - Percentage Share Breakdown for Merck & Co., Inc., and Others......88
Table 84: Market Shares of Leading Vildagliptin/Metformin Manufacturers by Value Sales in India (2015) - Percentage Share Breakdown for Novartis India Ltd., USV Pvt Ltd., and Others......89
Table 85: Market Shares of Leading Sitagliptin/Metformin Brands by Value Sales in India (2015) - Percentage Share Breakdown for Janumet, and Others......90
Table 86: Market Shares of Leading Vildagliptin/Metformin Brands by Value Sales in India (2015) - Percentage Share Breakdown for Galvus Met, Jalra M, and Others......91
Table 87: Market Shares of Leading Metformin Suppliers in India (2015) - Percentage Share Breakdown by Value for Harman Finochem Ltd., USV Pharmaceuticals Ltd., Wanbury Limited and Others......92
Table 88: DPP-4 Inhibitors Market by Prescription in the US (2015) - Percentage Share Breakdown by Volume for Janumet (Sitagliptin + Metformin), Januvia (Sitagliptin), Kombiglyze XR (Saxagliptin + Metformin), Onglyza (Saxagliptin), and Others......93
Capecitabine......94
Table 89: Antimetabolites Market by Type Worldwide (2015) - Percentage Share Breakdown by Value for Capecitabine, Gemcitabine, Pemetrexed, TS-1, and Others......94
Table 90: Anti-Cancer Drugs Market by Product Type in China (2015) - Percentage Share Breakdown by Value for Anastrozole, Capecitabine, Cetuximab, Compound kushen, Docetaxel, Epirubicin, Erlotinib, Gefitinib, Gemcitabine, Goserelin, Interferon α-2a, Interferon α-2b, Irinotecan, Kangai, Lentinan, Letrozole, Oxaliplatin, Paclitaxel, Pemetrexed, Pidotimod, RhG-CSF, RhIL-2, Rituximab, Sorafenib, Sshenqi Fuzheng, Thymopentin, Thymosin a1, Trastuzmmab, Triptorelin, TS-1, and Others......95
Glucosamine......96
Table 91: Dietary Supplements Retail Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Fish Oil, Glucosamine, Krill Oil, Magnesium, Multi-Vitamins, Vitamin B, Vitamin C, Vitamin D, Other Herbal, and Others......96
Table 92: Nutritional Supplement Market by Category Worldwide (2015) - Percentage Share Breakdown by Value for B Vitamins, Calcium Probiotics, Glucosamine and Chondroitin, Omega-3 Fish Oils, Vitamin A, Vitamin C, Vitamin E, and Others......97
Table 93: Supplements Sales through Supermarkets, Drugstores and Mass Merchandisers (excluding Wal-Mart) by Category in the US (2015) - Percentage Share Breakdown by Value for Adult Multivitamins, Calcium, Essential Fatty Acids (Fish Oils), Glucosamine and Chondroitin, Vitamin B, and Others......98
PALONOSETRON......99
Table 94: 5-HT3 Antagonist Market by Drug Worldwide (2015) - Percentage Share Breakdown by Value for GRANISETRON, ONDANSETRON AND PALONOSETRON (ALOXI)......99
Diabetes Drugs......100
Table 95: Market Shares of Leading Diabetes Care Companies Worldwide (2014) - Percentage Breakdown by Value Sales for Bristol-Myers Squibb (Incl Amylin), Eli Lilly and Company, Merck & Co., Inc., Novo Nordisk A/S, Sanofi S.A. and Others......100
Table 96: Market Shares of Leading Diabetes Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Novo Nordisk A/S, Pfizer, Inc., Sanofi S.A., and Others......101
Table 97: Market Shares of Leading Anti-Diabetic Drug Manufacturers in India (2014) - Percentage Breakdown by Value for Abbott Healthcare Pvt Ltd., Biocon Limited, Lupin Pharmaceuticals, Inc., MSD Pharmaceuticals Private Limited, Sanofi-Aventis Groupe, Sun Pharmaceutical Industries Ltd., Wockhardt Ltd., and Others......102
Hepatitis B Drugs......103
Table 98: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales in Korea (2014) - Percentage Breakdown for Bemis Company, Inc. (BMS), Bukwang Pharmaceutical Co., Ltd (Levovir), GlaxoSmithKline Plc (Hopsera, Zeffix), Novartis International AG (Sebivo), and Others......103
Table 99: Market Shares of Leading Hepatitis B Drug Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for Bemis Company, Inc.(Baraclude), F. Hoffmann-La Roche AG (Pegasys), GlaxoSmithKline Plc (Hepsera, Zeffix), and Novartis International AG (Sebivo)......104
Cancer Drugs......105
Table 100: Market Shares of Leading Oncology Product Manufacturers Worldwide (2015) - Percentage Breakdown by Value for Fresenius SE & Co., and Others......105
Table 101: Market Shares of Leading Oncology/Hematology Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, Amgen, Inc., AstraZeneca Plc, Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......106
Table 102: Market Shares of Leading Oncology Drug Manufacturers in China (2015) - Percentage Share Breakdown by Value for Astrazeneca, Jiangsu Hengrui Medicine Co., Ltd., Roche Group and Others......107
Table 103: Anti-Cancer Drugs Market by Type in China (2015) - Percentage Share Breakdown by Value for Alkylating Agents, Antibiotics, Antimetabolites, Hormonal Agents, Immunostimulant, Plant Alkaloids, and Others......108
Breast Cancer Drugs......109
Table 104: Market Shares of Leading Breast Cancer Drugs by Value Sales in China (2014) - Percentage Breakdown for Alkylating Agents, Antimetabolite, Antitumor Antibiotics, Antitumor Antihormone, Antitumor Botanicals, Monoclonal Antibodies, Targeted Small Molecule Agents, and Others......109
Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL)......110
Table 105: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Chronic Lymphocytic Leukemia (CLL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......110
Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL)......111
Table 106: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory (RR) Indolent Non-Hodgkin's Lymphoma (iNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib, Idelalisib and Others......111
Table 107: Market Shares of Leading Drugs for Treatment of Relapsed/Refractory Aggressive Non-Hodgkin Lymphoma (R/R- aNHL) in the US (2015) - Percentage Share Breakdown by Value for Ibrutinib and Others......112
Respiratory Therapeutics......113
Table 108: Market Shares of Leading Respiratory Therapeutic Providers by Value Sales Worldwide (2014) - Percentage Breakdown for AstraZeneca Plc, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......113
Table 109: Sino Biopharmaceutical Ltd.'s Sales by Therapeutic Area (2015) - Percentage Share Breakdown by Value for Analgesic, Cardio-cerebral Vascular (CCV), Hepatitis, Oncology, Parenteral Nutritious, and Others......114
Table 110: Sino Biopharmaceutical Ltd.'s Hepatitis Medicines Sales by Category (2015) - Percentage Share Breakdown by Value for Ming Zheng, Runzhong, Tianqingganmei, Tianqingganping, and Others......115
Table 111: Sino Biopharmaceutical Ltd.'s Parenteral Nutritious Medicines Sales by Category (2015) - Percentage Share Breakdown by Value for Xinhaineng, and Others......116
Table 112: Sino Biopharmaceutical Ltd.'s Orthopedic Medicines Sales by Category (2015) - Percentage Share Breakdown by Value for New Ossifies Estriol, and Others......117
Table 113: Sino Biopharmaceutical Ltd.'s Anti-infectious Medicines Sales by Category (2015) - Percentage Share Breakdown by Value for Tiance, and Others......118
Table 114: Sino Biopharmaceutical Ltd.'s Respiratory System Medicines Sales by Category (2015) - Percentage Share Breakdown by Value for Chia Tai Suke, Tianqingsule, and Others......119
Table 115: Sino Biopharmaceutical Ltd.'s Anorectal Medicines Sales by Category (2015) - Percentage Share Breakdown by Value for Getai, and Others......120
Table 116: Sino Biopharmaceutical Ltd.'s Diabetic Medicines Sales by Category (2015) - Percentage Share Breakdown by Value for Taibai, and Others......121
Table 117: Sino Biopharmaceutical Ltd.’s Sales by Business Segment (2014-2015) in Percentage for Modernized Chinese Medicines and Chemical Medicines, and Others......122
Table 118: Sino Biopharmaceutical Ltd.’s Sales by Business Segment (2013-2014) in Percentage for Modernized Chinese Medicines and Chemical Medicines and Others......123
Table 119: Sino Biopharmaceutical Ltd.'s Cardio-Cerebral Vascular (CCV) Medicines Sales by Category in China (2015) - Percentage Market Share Breakdown by Value for Kaishi Injection, Spring Injection, Tianqingganan, TianqingninG, and Others......124